[Transient diabetes mellitus during L-asparaginase therapy].
D000293:Adolescent; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced* / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007328:Insulin / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D008297:Male
D007328:Insulin; D001215:Asparaginase
Atmeneti jellegü diabetes mellitus L-asparaginase kezelés kapcsán